Dr. Ulrike (Riki) Peters

For the Media

Dr. Ulrike (Riki) Peters

Dr. Ulrike Peters is a member of Fred Hutch's Public Health Sciences Division.  Her research centers on the genetic and molecular epidemiology of common complex diseases, including cancer, obesity, type 2 diabetes, and cardiovascular diseases, as well as intermediate traits, including inflammation and metabolic measurements.

Resources for more information

Overview of Ulrike Peters' Research Focus

Ulrike Peters - Short Bio

Ulrike Peters - Brief Curriculum Vitae
Appointments, affiliations and researcher interests

Peters Studies
The Peters group are studying the impact of common and rare genetic variants across the entire genome, as well as interactions between genetic variants and environmental factors (such as diet, exercise, smoking and aspirin use).

Public Health Sciences Division
Using large populations as their "laboratory," our public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors. Identifying such cancer causes can lead to better cancer-detection methods and new ways to help people adopt healthier lifestyles to minimize or avoid their risk of getting the disease in the first place.

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.

Photos

Download

Download photos of Dr. Ulrike Peters.

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.